Kneat.com (TSX: KSI, OTCQC: KSIOF) has secured a three-year Master Services Agreement with a major US-based clinical diagnostics manufacturer. The unnamed customer operates in over 40 countries with 14,000+ employees and is part of a larger life sciences organization employing more than 60,000 people. The agreement focuses on digitizing the customer's equipment validation process using Kneat's Gx platform. The client specializes in providing diagnostic solutions to hospitals, laboratories, and physicians' offices globally. This partnership aligns with the broader industry trend of life sciences companies transitioning from manual, paper-based validation processes to digital solutions for improved quality, compliance, and market efficiency.
Kneat.com (TSX: KSI, OTCQC: KSIOF) ha siglato un accordo quadro triennale con un importante produttore statunitense di diagnostica clinica. Il cliente, il cui nome non è stato rivelato, opera in oltre 40 paesi con più di 14.000 dipendenti ed è parte di un'organizzazione più ampia nel settore delle scienze della vita che impiega oltre 60.000 persone. L'accordo mira a digitalizzare il processo di convalida delle apparecchiature del cliente utilizzando la piattaforma Gx di Kneat. Il cliente è specializzato nel fornire soluzioni diagnostiche a ospedali, laboratori e studi medici a livello globale. Questa collaborazione si inserisce nella tendenza più ampia del settore delle scienze della vita, che sta passando da processi di convalida manuali e cartacei a soluzioni digitali per migliorare qualità, conformità ed efficienza sul mercato.
Kneat.com (TSX: KSI, OTCQC: KSIOF) ha asegurado un acuerdo maestro de servicios por tres años con un importante fabricante estadounidense de diagnósticos clínicos. El cliente, cuyo nombre no se ha revelado, opera en más de 40 países con más de 14,000 empleados y forma parte de una organización más grande en ciencias de la vida que emplea a más de 60,000 personas. El acuerdo se centra en digitalizar el proceso de validación de equipos del cliente utilizando la plataforma Gx de Kneat. El cliente se especializa en ofrecer soluciones diagnósticas a hospitales, laboratorios y consultorios médicos a nivel mundial. Esta alianza se alinea con la tendencia general de la industria de ciencias de la vida, que está pasando de procesos manuales y basados en papel a soluciones digitales para mejorar la calidad, el cumplimiento y la eficiencia en el mercado.
Kneat.com(TSX: KSI, OTCQC: KSIOF)는 미국 주요 임상 진단 제조업체와 3년간 마스터 서비스 계약을 체결했습니다. 이름이 공개되지 않은 이 고객사는 40개국 이상에서 14,000명 이상의 직원을 보유하고 있으며, 60,000명 이상의 직원을 둔 더 큰 생명과학 조직의 일부입니다. 이 계약은 Kneat의 Gx 플랫폼을 활용해 고객의 장비 검증 프로세스를 디지털화하는 데 중점을 둡니다. 이 고객사는 전 세계 병원, 실험실, 의사 사무실에 진단 솔루션을 제공하는 데 특화되어 있습니다. 이번 파트너십은 생명과학 산업 전반에서 수작업 및 종이 기반 검증 프로세스에서 디지털 솔루션으로 전환하여 품질, 준수 및 시장 효율성을 향상시키려는 추세와 일치합니다.
Kneat.com (TSX : KSI, OTCQC : KSIOF) a conclu un contrat-cadre de services de trois ans avec un important fabricant américain de diagnostics cliniques. Le client, dont le nom n'a pas été divulgué, opère dans plus de 40 pays avec plus de 14 000 employés et fait partie d'une organisation plus large dans le domaine des sciences de la vie employant plus de 60 000 personnes. L'accord vise à numériser le processus de validation des équipements du client en utilisant la plateforme Gx de Kneat. Le client est spécialisé dans la fourniture de solutions diagnostiques aux hôpitaux, laboratoires et cabinets médicaux à l'échelle mondiale. Ce partenariat s'inscrit dans la tendance générale de l'industrie des sciences de la vie, qui passe des processus de validation manuels et papier à des solutions numériques pour améliorer la qualité, la conformité et l'efficacité sur le marché.
Kneat.com (TSX: KSI, OTCQC: KSIOF) hat einen drei Jahre gültigen Master-Service-Vertrag mit einem großen US-amerikanischen Hersteller klinischer Diagnostik abgeschlossen. Der nicht namentlich genannte Kunde ist in über 40 Ländern tätig, beschäftigt mehr als 14.000 Mitarbeiter und ist Teil einer größeren Life-Sciences-Organisation mit über 60.000 Beschäftigten. Der Vertrag konzentriert sich auf die Digitalisierung des Gerätevalidierungsprozesses des Kunden mittels der Gx-Plattform von Kneat. Der Kunde ist auf die Bereitstellung diagnostischer Lösungen für Krankenhäuser, Labore und Arztpraxen weltweit spezialisiert. Diese Partnerschaft entspricht dem allgemeinen Branchentrend, dass Life-Sciences-Unternehmen von manuellen, papierbasierten Validierungsprozessen auf digitale Lösungen umsteigen, um Qualität, Compliance und Markteffizienz zu verbessern.
Positive
Secured a three-year Master Services Agreement with a major global diagnostics company
Client has significant global presence (40+ countries) and large workforce (14,000+ employees)
Potential for expansion within the larger parent organization (60,000+ employees)
Demonstrates Kneat's ability to win contracts with major healthcare industry players
Negative
Initial implementation limited to equipment validation process only
Financial terms and contract value not disclosed
LIMERICK, Ireland, May 15, 2025 (GLOBE NEWSWIRE) -- kneat.com, inc. (TSX: KSI) (OTCQC: KSIOF), a leader in digitizing and automating validation and quality processes, is pleased to announce that a manufacturer of clinical diagnostics for the healthcare industry (“the Company”) has signed a three-year Master Services Agreement with Kneat.
The Company, which is headquartered in the United States, operates in more than 40 countries and employs over 14,000 people, provides a comprehensive range of clinical diagnostics and biomedical testing for the healthcare industry. Its diagnostic solutions are used by hospitals, laboratories and physicians’ offices around the world for routine and complex clinical testing. As a division of a larger life sciences organization with more than 60,000 employees, the Company will use Kneat Gx initially to digitize its equipment validation process.
“The quality of our platform, its maturity in the market and the expertise and commitment of our team enabled this win,” said Eddie Ryan, Kneat’s CEO. “Adopting Kneat is another step in this customer’s longstanding commitment to continuous improvement. We look forward to working with them to deliver the efficiency and compliance benefits that characterize Kneat.”
As the many segments of life sciences seek to improve quality, compliance and speed to market, more and more companies are shifting from a manual, paper-based validation process to one that is streamlined and harmonized through digitalization.
About Kneat
Kneat Solutions provides leading companies in highly regulated industries with unparalleled efficiency in validation and compliance through its digital validation platform Kneat Gx. As an industry leader in customer satisfaction, Kneat boasts an excellent record for implementation, powered by our user-friendly design, expert support, and on-demand training academy. Kneat Gx is an industry-leading digital validation platform that enables highly regulated companies to manage any validation discipline from end-to-end. Kneat Gx is fully ISO 9001 and ISO 27001 certified, fully validated, and 21 CFR Part 11/Annex 11 compliant. Multiple independent customer studies show up to 40% reduction in documentation cycle times, up to 20% faster speed to market, and a higher compliance standard.
Cautionary and Forward-Looking Statements
Except for the statements of historical fact contained herein, certain information presented constitutes “forward-looking information” within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat’s business development activities, the use and implementation timelines of Kneat’s software within the customer’s validation processes, the ability and intent of the customer to scale the use of Kneat’s software within the customer’s organization, and the compliance of Kneat’s platform under regulatory audit and inspection. While such forward-looking statements are expressed by Kneat, as stated in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to important risks and uncertainties. As a result of these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, given that they involve risks and uncertainties.
Kneat does not undertake any obligation to release publicly revisions to any forward-looking statement, except as may be required under applicable securities laws. Investors should not assume that any lack of update to a previously issued forward-looking statement constitutes a reaffirmation of that statement. Continued reliance on forward-looking statements is at an investor’s own risk.
What is the new contract Kneat (KSIOF) signed in May 2025?
Kneat signed a three-year Master Services Agreement with a major US-based clinical diagnostics manufacturer to digitize their equipment validation process using the Kneat Gx platform.
How large is the diagnostic company that partnered with Kneat (KSIOF)?
The company operates in over 40 countries, employs more than 14,000 people, and is part of a larger life sciences organization with 60,000+ employees.
What will Kneat's Gx platform be used for in this new partnership?
The Kneat Gx platform will initially be used to digitize the company's equipment validation process, replacing manual, paper-based systems.
What is the value of Kneat's (KSIOF) new diagnostic company contract?
The financial terms and value of the three-year Master Services Agreement were not disclosed in the announcement.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
